HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1795028Generated: November 2, 2026
Triethylamine → (2R)-3-(2-methylbenzothiazol-5-yloxy)-1-[4-({5-[4-(trifluoromethyl)phenyl](4,5-dihydroisoxazol-3-yl)}methyl)piperazinyl]propan-2-ol
https://huagongshe.com/reaction/1795028
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 3-(Chloromethyl)-5-(4-(trifluoromethyl)phenyl)-4,5-dihydroisoxazole | HCID 22184699 | — |
| Reactant | (2R)-1-(2-methylbenzothiazol-5-yloxy)-3-piperazinylpropan-2-ol | HCID 29943216 | — |
| Solvent | 2-Methyl-2-butanol | HCID 6405 | — |
| Product | (2R)-3-(2-methylbenzothiazol-5-yloxy)-1-[4-({5-[4-(trifluoromethyl)phenyl](4,5-dihydroisoxazol-3-yl)}methyl)piperazinyl]propan-2-ol | HCID 11756913 | 23.4% |
Reaction Steps
To a stirred mixture of (2R)-1-(2-methylbenzothiazol-5-yloxy)-3-piperazinylpropan-2-ol (30 mg, 0.08 mmol) in tert-amylalcohol (5 mL) was added triethylamine (40 μL, 0.30 mmol), followed by 3-(chloromethyl)-5-(4-(trifluoromethyl)phenyl)-4,5-dihydroisoxazole (20 mg, 0.08 mmol). The resulting mixture was stirred at 95° C. for 12 hours, concentrated under reduced pressure, and purified by preparative chromatograph (1:19 MeOH:CH2Cl2) to afford (2R)-3-(2-methylbenzothiazol-5-yloxy)-1-[4-({5-[4-(trifluoromethyl)phenyl](4,5-dihydroisoxazol-3-yl)}methyl)piperazinyl]propan-2-ol (10 mg, M+1=535.1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07026321B2 |
|---|
| Source dataset | uspto-grants-2006_04 |
|---|
| ORD ID | ord-e2cf7a390fc24da4b4f13c7113c4280b |
|---|
| Source note | uspto-grants-2006_04 |
|---|